Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity

Mohit Narwal, Jarkko Koivunen, Teemu Haikarainen, Ezeogo Obaji, Ongey E. Legala, Harikanth Venkannagari, Päivi Joensuu, Taina Pihlajaniemi, Lari Lehtiö

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Tankyrases are ADP-ribosyltransferases that play key roles in various cellular pathways, including the regulation of cell proliferation, and thus, they are promising drug targets for the treatment of cancer. Flavones have been shown to inhibit tankyrases and we report here the discovery of more potent and selective flavone derivatives. Commercially available flavones with single substitutions were used for structure-activity relationship studies, and cocrystal structures of the 18 hit compounds were analyzed to explain their potency and selectivity. The most potent inhibitors were also tested in a cell-based assay, which demonstrated that they effectively antagonize Wnt signaling. To assess selectivity, they were further tested against a panel of homologous human ADP-ribosyltransferases. The most effective compound, 22 (MN-64), showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition. This work forms a basis for rational development of flavones as tankyrase inhibitors and guides the development of other structurally related inhibitors.

Original languageEnglish (US)
Pages (from-to)7880-7889
Number of pages10
JournalJournal of Medicinal Chemistry
Volume56
Issue number20
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Tankyrases
Flavones
Isoenzymes
ADP Ribose Transferases
flavone
Structure-Activity Relationship
Cell Proliferation
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Narwal, M., Koivunen, J., Haikarainen, T., Obaji, E., Legala, O. E., Venkannagari, H., ... Lehtiö, L. (2013). Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity. Journal of Medicinal Chemistry, 56(20), 7880-7889. https://doi.org/10.1021/jm401463y

Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity. / Narwal, Mohit; Koivunen, Jarkko; Haikarainen, Teemu; Obaji, Ezeogo; Legala, Ongey E.; Venkannagari, Harikanth; Joensuu, Päivi; Pihlajaniemi, Taina; Lehtiö, Lari.

In: Journal of Medicinal Chemistry, Vol. 56, No. 20, 2013, p. 7880-7889.

Research output: Contribution to journalArticle

Narwal, M, Koivunen, J, Haikarainen, T, Obaji, E, Legala, OE, Venkannagari, H, Joensuu, P, Pihlajaniemi, T & Lehtiö, L 2013, 'Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity', Journal of Medicinal Chemistry, vol. 56, no. 20, pp. 7880-7889. https://doi.org/10.1021/jm401463y
Narwal, Mohit ; Koivunen, Jarkko ; Haikarainen, Teemu ; Obaji, Ezeogo ; Legala, Ongey E. ; Venkannagari, Harikanth ; Joensuu, Päivi ; Pihlajaniemi, Taina ; Lehtiö, Lari. / Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity. In: Journal of Medicinal Chemistry. 2013 ; Vol. 56, No. 20. pp. 7880-7889.
@article{d89dbaee076e4ab593d9686864386b69,
title = "Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity",
abstract = "Tankyrases are ADP-ribosyltransferases that play key roles in various cellular pathways, including the regulation of cell proliferation, and thus, they are promising drug targets for the treatment of cancer. Flavones have been shown to inhibit tankyrases and we report here the discovery of more potent and selective flavone derivatives. Commercially available flavones with single substitutions were used for structure-activity relationship studies, and cocrystal structures of the 18 hit compounds were analyzed to explain their potency and selectivity. The most potent inhibitors were also tested in a cell-based assay, which demonstrated that they effectively antagonize Wnt signaling. To assess selectivity, they were further tested against a panel of homologous human ADP-ribosyltransferases. The most effective compound, 22 (MN-64), showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition. This work forms a basis for rational development of flavones as tankyrase inhibitors and guides the development of other structurally related inhibitors.",
author = "Mohit Narwal and Jarkko Koivunen and Teemu Haikarainen and Ezeogo Obaji and Legala, {Ongey E.} and Harikanth Venkannagari and P{\"a}ivi Joensuu and Taina Pihlajaniemi and Lari Lehti{\"o}",
year = "2013",
doi = "10.1021/jm401463y",
language = "English (US)",
volume = "56",
pages = "7880--7889",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "20",

}

TY - JOUR

T1 - Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity

AU - Narwal, Mohit

AU - Koivunen, Jarkko

AU - Haikarainen, Teemu

AU - Obaji, Ezeogo

AU - Legala, Ongey E.

AU - Venkannagari, Harikanth

AU - Joensuu, Päivi

AU - Pihlajaniemi, Taina

AU - Lehtiö, Lari

PY - 2013

Y1 - 2013

N2 - Tankyrases are ADP-ribosyltransferases that play key roles in various cellular pathways, including the regulation of cell proliferation, and thus, they are promising drug targets for the treatment of cancer. Flavones have been shown to inhibit tankyrases and we report here the discovery of more potent and selective flavone derivatives. Commercially available flavones with single substitutions were used for structure-activity relationship studies, and cocrystal structures of the 18 hit compounds were analyzed to explain their potency and selectivity. The most potent inhibitors were also tested in a cell-based assay, which demonstrated that they effectively antagonize Wnt signaling. To assess selectivity, they were further tested against a panel of homologous human ADP-ribosyltransferases. The most effective compound, 22 (MN-64), showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition. This work forms a basis for rational development of flavones as tankyrase inhibitors and guides the development of other structurally related inhibitors.

AB - Tankyrases are ADP-ribosyltransferases that play key roles in various cellular pathways, including the regulation of cell proliferation, and thus, they are promising drug targets for the treatment of cancer. Flavones have been shown to inhibit tankyrases and we report here the discovery of more potent and selective flavone derivatives. Commercially available flavones with single substitutions were used for structure-activity relationship studies, and cocrystal structures of the 18 hit compounds were analyzed to explain their potency and selectivity. The most potent inhibitors were also tested in a cell-based assay, which demonstrated that they effectively antagonize Wnt signaling. To assess selectivity, they were further tested against a panel of homologous human ADP-ribosyltransferases. The most effective compound, 22 (MN-64), showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition. This work forms a basis for rational development of flavones as tankyrase inhibitors and guides the development of other structurally related inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=84886534150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886534150&partnerID=8YFLogxK

U2 - 10.1021/jm401463y

DO - 10.1021/jm401463y

M3 - Article

VL - 56

SP - 7880

EP - 7889

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 20

ER -